Pituitary tumor transforming gene (PTTG), the human ortholog of securin, is an oncogene. Few normal tissues express PTTG, although in the testis, it is more abundantly expressed. In cancer, however, its wide expression has been directly correlated with the proliferation and angiogenesis, although very little is known about the overall regulation of the PTTG gene. In this study, we investigate the role of the calciumsensing receptor (CaR), a G protein-coupled receptor (GPCR), in regulating PTTG in a widely used model of humoral hypercalcemia of malignancy, the rat H-500 Leydig cell testicular cancer. We show that extracellular calcium (Ca 
T HE MAMMALIAN ORTHOLOG of securin, a protein crucially involved in initiation of sister-chromatid separation, pituitary tumor transforming gene (PTTG), was discovered in rat pituitary adenoma cell lines by differential mRNA display PCR (1, 2) . Despite being involved in cell division, PTTG in mammals is not ubiquitously expressed but displays a restrictive expression. Other normal tissues besides pituitary adenomas in which PTTG mRNA is expressed include the testis and fetal liver, as assessed by Northern blot analysis. The extremely abundant expression of PTTG in the testis is stage specific and is greatest in spermatocytes and spermatids during the rat spermatogenic cycle (3) . The important role of PTTG in the testis has been revealed by testicular hypoplasia in mice lacking the PTTG gene (4) .
Although the expression profile of PTTG is limited to very few tissues, it is expressed and often overexpressed in most cancers including breast, colon, and ovary cancers (5) . PTTG has also been shown to induce proliferation and transformation in vitro and promote tumor formation in nude athymic mice containing PTTG-overexpressing NIH-3T3 fibroblasts (1, 6) . Another promalignant characteristic of this model of PTTG overexpression is induction of angiogenesis through production of basic fibroblast growth factor (bFGF) (7) . Furthermore, a positive correlation has been demonstrated between the levels of PTTG expression and the degree of pituitary tumor invasiveness (8) , although our overall understanding of PTTG regulation is scanty. Given the emerging promalignant/oncogenic roles of PTTG and the fact that it is highly abundant in the testis, we sought to study its regulation in H-500 rat primary Leydig cancer cells, a model for humoral hypercalcemia of malignancy (HHM) (9) . Upon implantation into adult male rats, H-500 cells vigorously proliferate. The most widely studied aspect of H-500 cells so far is the regulation of secretion of PTHrP, the major mediator of HHM. We and others have shown that elevated extracellular calcium (Ca 2ϩ o ) via a G protein-coupled calcium-sensing receptor (CaR) up-regulates PTHrP secretion and synthesis through a mechanism involving multiple MAPKs (10 -12) . A similar role of the CaR has been reported in other cancers, such as breast and prostate cancer, making it a likely therapeutic target for antagonizing its function using calcilytics (CaR antagonists).
Unlike the breast and prostate tumors, the H-500 Leydig tumor does not metastasize. Instead, it is marked by robust 
Materials and Methods

Cell culture
The Rice H-500 rat Leydig cell tumor was obtained from the National Cancer Institute-Frederick Cancer Research and Development Center DCT Tumor Repository (Frederick, MD). Male Fischer 344 rats (Harlan Sprague Dawley, Inc., Indianapolis, IN) weighing 200 -220 g (age, 10 wk) were used. A fragment of the H-500 tumor or dispersed H-500 cells (10 6 per rat) were implanted or injected sc, respectively, in each rat, and the tumors were allowed to grow for 8 -14 d. The encapsulated tumor was then excised, rinsed several times with cell culture medium (see below), minced into small pieces, and dispersed by repeated pipetting and several passages through a 22-gauge needle. Dispersed H-500 cells were subsequently plated in RPMI 1640 medium supplemented with 10% fetal bovine serum and 100 U/ml penicillin-100 g/ml streptomycin and grown at 37 C in a humidified 5% CO 2 atmosphere. Cells were passaged every 4 -5 d using 0.05% trypsin-0.53 mm EDTA and used for experimentation within the first 10 passages. All cell culture reagents were purchased from GIBCO-BRL (Grand Island, NY), with the exception of fetal bovine serum, which was obtained from Gemini Bio-Products (Calabasas, CA). Rats were handled in accordance with local institutional guidelines.
Northern blot analysis
To study whether high Ca 2ϩ o affects the expression of PTTG mRNA, we performed Northern blot analysis as previously described (13) . In brief, cellular RNA was isolated (14) using Trizol reagent (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. The RNA recovered was quantitated by spectrophotometry, and aliquots of 20 g total RNA from H-500 cells incubated at low Ca 2ϩ o (0.5 mm) or high Ca 2ϩ o (7.5 mm) concentrations were loaded on a formaldehyde agarose gel after denaturation. The gel was stained with ethidium bromide to visualize RNA standards and rRNA so that equal loading of RNA from the various experimental samples could be documented. The RNA was then blotted onto nylon membranes (Duralon; Stratagene, La Jolla, CA). Blots were hybridized with full-length cDNA probe for rat PTTG and washed under high-stringency conditions as described previously (11) . Equal loading was also confirmed by reprobing the membranes with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA. Specific radioactive signals were analyzed on a Molecular Dynamics, Inc., PhosphorImager (Sunnyvale, CA) with the ImageQuant program.
Infecting H-500 cells with CaR constructs in recombinant adenoassociated virus (rAAV)
High-efficiency gene transfer into H-500 cells was accomplished using a rAAV-based method. The CaR sequence with a naturally occurring, dominant-negative mutation (R185Q), as well as the same vector containing the cDNA for the ␤-galactosidase protein (BG), were under the control of a cytomegalovirus immediate-early promoter element and packaged as previously described (15) . The BG served as the control for nonspecific effects of rAAV infection. Cells were seeded (1000 cells/ well) in 96-well plates in 0.1 ml of growth medium and cultured overnight. About 1000 virus particles/cell (as optimized by pilot studies) were used to infect each well. Cells were washed once with serum-free ␣-MEM. Virus particles were then added, and the culture was incubated for 90 min in serum-free medium at 37 C in a cell-culture incubator. Equal volumes of RPMI 1640 containing 20% serum were added to the cells to achieve a final serum concentration of 10%. The cells were then cultured for 48 h, and experiments with low and high calcium concentrations were performed as described in subsequent sections.
Quantitative real-time PCR
To amplify PTTG (NM_022391), VEGF (NM_031836), and GAPDH cDNA, sense and antisense oligonucleotide primers were designed based on the published cDNA sequences using the Primer Express version 2.0.0 (Applied Biosystems, Foster City, CA). Oligonucleotides were obtained from Genosys (Woodlands, TX). The sequences of the primers were as follows: 5Ј-ATG ACC CTG GCG TGA AGA TTT-3Ј [PTTG sense, nucleotides (nt) 127-147], 5Ј-AAG CAG CAA CAG AGA CCA GAG C-3Ј (PTTG antisense, nt 227-206), 5Ј-AGC CTT GTT CAG AGC GGA GAA-3Ј (VEGF sense, nt 500 -520), 5Ј-TAA CTC AAG CTG CCT CGC CTT-3Ј (VEGF antisense, nt 606 -586), 5Ј-TTC AAT GGC ACA GTC AAG GC-3Ј (GAPDH sense), and 5Ј-TCA CCC CAT TTG ATG TTA GCG-3Ј (GAPDH antisense).
cDNA was synthesized with the Omniscript RT Kit (QIAGEN, Valencia, CA) using 2 g total RNA in a 20 l reaction volume. For real-time PCR, the cDNA was amplified using an ABI PRISM 7000 Sequence Detection System (Applied Biosystems). The double-stranded DNAspecific dye SYBR Green I was incorporated into the PCR buffer QuantiTech SYBR PCR (QIAGEN) to allow for quantitative detection of the PCR product in a 30-l reaction volume. The temperature profile of the reaction was 95 C for 10 min, 40 cycles of denaturation at 95 C for 15 sec, annealing at 60 C for 30 sec, and extension at 72 C for 30 sec. An internal housekeeping gene control, GAPDH, was used to normalize differences in RNA isolation, RNA degradation, and the efficiencies of the reverse transcription (RT). The size of the PCR product was first verified on a 1.5% agarose gel, followed by melting curve analysis thereafter.
Statistics
The data are presented as the mean Ϯ se of the indicated number of experiments. Data were analyzed by either one-way ANOVA followed by Dunnett's multiple comparison test or Student's t test when appropriate. P Ͻ 0.05 indicates a statistically significant difference. GAPDH was used to normalize differences in RNA isolation, RNA degradation, and/or the efficiency of the reverse transcription (RT) reaction (*, P Ͻ 0.05, n ϭ 5).
Results
High Ca 2ϩ
o induced PTTG expression as assessed by Northern blot analysis with a full-length PTTG cDNA probe (Fig. 1A) . Previously, we found that the EC 50 for PTHrP secretion by the H-500 cells is 5 mm Ca 2ϩ o (16) . Therefore, we chose 0.5 and 7.5 mm Ca 2ϩ o to be our low and high calcium concentrations, respectively. A 6-h incubation of H-500 cells with high (7.5 mm) Ca Figure  1A shows that actinomycin D markedly diminished PTTG expression at both low and high Ca 2ϩ o , suggesting that calcium induces de novo synthesis of PTTG mRNA.
Because PTTG is an oncogene, we were interested in the earliest time point of its induction by high Ca Fig. 2A) .
After determining the time course of PTTG mRNA induction, we studied the Ca (Fig. 2B) . We then sought to study whether this high Ca 2ϩ o -induced increase in PTTG mRNA is mediated by the G proteincoupled CaR. In the cells infected with rAAV expressing BG, Ca 2ϩ o dose-responsively stimulated PTTG mRNA, with 2.14 Ϯ 0.22-and 2.75 Ϯ 0.43-fold increases at 3.5 and 7.5 mm, respectively, compared with 0.5 mm calcium. Infecting H-500 cells with a dominant-negative CaR (R185Q) via rAAV resulted in a significant reduction in the Ca 2ϩ o -stimulated PTTG mRNA dose-response compared with cells infected with BG at 3.5 and 7.5 mm calcium (Fig. 3) .
Thus, high Ca 2ϩ o -induced PTTG mRNA up-regulation is indeed CaR mediated. To assess the specificity of the CaR in inducing this effect, we used ADP, which is the ligand of another GPCR, a purinergic receptor, that, like the CaR, is coupled to G␣ q/11 . We have previously shown ADP to be an agonist that is linked to G␣ q/11 through its receptor in H-500 cells, thereby eliciting intracellular calcium (Ca o -mediated PTTG expression was 2.14 Ϯ 0.22-and 2.75 Ϯ 0.43-fold greater than basal PTTG expression in the H-500 cells infected with BG ( a , P Ͻ 0.05 compared with low calcium). In cells infected with dominant-negative CaR, no effect was seen at 3.5 and 7.5 mM Ca 2ϩ o , a result that is significantly different from the response seen in the cells infected with BG ( b and c , P Ͻ 0.05, compared with 3.5 and 7.5 mM, respectively, in cells infected with BG). GAPDH was used to normalize differences in RNA isolation, RNA degradation, and/or the efficiency of the RT reaction.
ADP␤S (10
Ϫ6 m) did not show any change in PTTG mRNA expression (0.84 Ϯ 0.06) (Fig. 4) .
Up-regulation of PTTG has been shown to induce proliferation and angiogenesis (1, 7) . Therefore, in H-500 cells, we next investigated whether the high Ca 2ϩ o effect exerted by the CaR on PTTG expression also regulated the expression of the potent angiogenic factor, VEGF. Table 1 shows that high Ca 2ϩ o indeed up-regulated the mRNA of VEGF in H-500 cells stimulated for 18 h by 2.89 Ϯ 1.05-fold compared with low calcium.
Discussion
The purpose of this study was to understand the regulation of PTTG expression. Because PTTG is most abundantly expressed in rodent testis and is overexpressed in various cancer cells, H-500 Leydig cancer cells presented the appropriate combination of both of these features. Traditionally, H-500 cells serve as a nonmetastasizing model for HHM. PTHrP acts as the major mediator of this syndrome. Recently, we have unequivocally shown that CaR activation induces PTHrP secretion and synthesis in these cells, which involves participation of multiple MAPKs (11) . PTTG, like PTHrP, is regulated through the MAPKs (18) . Upon implantation in rats, H-500 cells, like other highly malignant cells, display a vigorous proliferative capacity along with angiogenesisfunctions that have been attributed to PTTG. The downstream mediators of PTTG involved in such processes are transactivation of c-myc, the oncogene that induces cellular proliferation, and bFGF, which induces angiogenesis (7, 19, 20) .
Here, we have shown that high Ca 2ϩ o , acting via the CaR, rapidly induces PTTG expression. Not surprisingly, given that PTTG is a proto-oncogene, its rapid activation by the CaR is not unusual; however, the sustained induction of PTTG by prolonged CaR activation is striking. Our current understanding of the regulation of PTTG expression is that 1) it is inhibited by cyclosporin A and hydrocortisone in T lymphocytes and 2) it is up-regulated by estrogen and bFGF in pituitary adenomas (20, 21) . Here, we have shown for the first time that a G␣ q/11 -coupled GPCR, the CaR, up-regulates PTTG expression in testis-derived rat Leydig cancer cells. This is not a nonspecific event caused by the activation of any GPCR because activation of a functional G␣ q/11 -coupled purinergic receptor in these cells by ADP␤S (a nondegradable form) failed to alter PTTG expression. However, based on this study, it would be premature to conclude that the CaR would uniformly up-regulate PTTG mRNA in other malignancies and especially malignancies with metastatic capacity. Also, the likelihood of a regulatory effect of the CaR on PTTG gene expression could be contingent on high endogenous expression of any tumor cell, such as the one we studied here.
PTTG has been demonstrated to be promalignant because it induces transformation, proliferation, and angiogenesis in various cancer cells. Here, we have shown the proangiogenic Cells were treated and mRNA preparation, cDNA synthesis, and real-time PCR were performed as described in Fig. 2 . High Ca 2ϩ o induces VEGF mRNA. Data were pooled from three independent experiments. GAPDH was used to normalize differences in RNA isolation, RNA degradation, and/or the efficiency of the RT. a P Ͻ 0.05 compared with low Ca 2ϩ o .
FIG. 4. ADP␤S, a purinergic ligand also coupled to G␣ q/11 , has no effect on PTTG mRNA. Cells were treated and mRNA preparation, cDNA synthesis, and real-time PCR were performed as described in Fig. 2 . High Ca 2ϩ o induces PTTG mRNA, whereas ADP␤S at 10 Ϫ6 M has no such effect. Data were pooled from three independent experiments. GAPDH was used to normalize differences in RNA isolation, RNA degradation, and/or the efficiency of the RT reaction ( a,b , P Ͻ 0.05 compared with low calcium and ADP␤S).
potential of high Ca 2ϩ o as evidenced by its induction of VEGF mRNA in H-500 cells. It is relevant in this regard to mention that, in a separate study, we demonstrated induction of proliferation of H-500 cells by the CaR (Tfelt-Hansen, J., N. Chattopadhyay, S. Yano, D. Kanuparthi, P. Rooney, P. Schwarz, and E. M. Brown, manuscript submitted), which could plausibly be mediated by induction of PTTG expression. Various oncogenes, such as raf, ras, and src, are known to regulate VEGF (22) . Our findings demonstrate, for the first time, that high Ca 2ϩ o by up-regulating VEGF may facilitate angiogenesis by induction of endothelial proliferation and vascular permeability, which is pertinent for a HHM model such as H-500 cells. However, whether this effect is direct or mediated via PTTG awaits further study. Finally, our findings may have an important bearing on the pathogenesis of HHM in which high Ca 2ϩ o levels and consequent CaR activation contribute to tumor progression. Induction of PTTG by the CaR may be a newly identified effector arm in processes such as proliferation and/or angiogenesis.
